Management of Enoxaparin Before ERCP
Yes, enoxaparin must be held before ERCP with sphincterotomy, with the last dose administered 12-24 hours prior to the procedure. 1, 2
Risk Classification of ERCP
ERCP with sphincterotomy is classified as a high-risk bleeding procedure by the British Society of Gastroenterology and European Society of Gastrointestinal Endoscopy. 1, 3 This classification mandates specific anticoagulation management protocols that differ substantially from low-risk diagnostic procedures.
- ERCP with biliary or pancreatic stenting alone (without sphincterotomy) is considered low-risk and requires different management. 1
- The addition of sphincterotomy, large balloon papillary dilation, or ampullectomy elevates the procedure to high-risk status. 1
Discontinuation Protocol for Enoxaparin
Standard Timing
Discontinue enoxaparin 12-24 hours before ERCP if sphincterotomy or other high-risk interventions are planned. 2 This timing allows adequate clearance of anticoagulant effect while minimizing thrombotic risk.
Bridging Considerations
The decision to hold enoxaparin depends on whether it is being used as:
- Primary anticoagulation (therapeutic dosing): Hold 12-24 hours before procedure 2
- Bridge therapy for warfarin: The same 12-24 hour hold applies, with transition to unfractionated heparin per institutional protocol if needed 2
For patients at high thrombotic risk (mechanical mitral valve, recent stent placement within specified timeframes, or atrial fibrillation with mitral stenosis), coordinate with cardiology before discontinuing enoxaparin, as these patients may require transition to unfractionated heparin that can be stopped closer to procedure time. 1, 3
Renal Function Adjustment
While the evidence specifically addresses CABG rather than ERCP, patients with impaired renal function (CrCl 30-50 mL/min) may require longer discontinuation periods due to prolonged enoxaparin clearance. 4 Consider extending the hold to 24 hours in patients with significant renal impairment to ensure adequate drug clearance.
Resumption After ERCP
Resume enoxaparin 24-72 hours after the procedure depending on bleeding risk and adequacy of hemostasis. 3 For high-risk procedures like ERCP with sphincterotomy, err toward the longer end of this interval (48-72 hours) to minimize post-procedural bleeding complications. 1
- Verify adequate hemostasis before restarting anticoagulation 3
- Coordinate resumption timing with the endoscopist who performed the procedure 1
Critical Pitfalls to Avoid
Never continue therapeutic-dose enoxaparin through ERCP with sphincterotomy, as this dramatically increases bleeding risk without providing meaningful additional thrombotic protection during the brief interruption period. 1, 5
Do not use bridging therapy with LMWH for patients at low thrombotic risk, as this increases bleeding complications without reducing thrombotic events. 1 Bridging is reserved only for patients at genuinely high thrombotic risk (mechanical mitral valve, recent drug-eluting stent <12 months, bare metal stent <1 month). 1
Avoid holding enoxaparin for longer than necessary (>24 hours before procedure), as each additional day off anticoagulation increases thrombotic risk, particularly in patients with active venous thromboembolism or high-risk atrial fibrillation. 6